PAMELA BOLING: Open Payments
NPI 1750658399 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 50 payments from 20 companies in 2025. Trend: 2023 $476 · 2024 $590 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $212 |
| AstraZeneca Pharmaceuticals LP | 9 | $151 |
| Amgen Inc. | 5 | $73 |
| Lilly USA, LLC | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Noven Therapeutics, LLC | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
Products named: Auvelity, BREZTRI, EVENITY, VOQUEZNA, TRINTELLIX, Xelstrym, CAPLYTA, XIFAXAN.
Industry payments across IN — which companies pay providers there.
